Patient Login
Contact
Partner Login
FAQ
Toggle navigation
Patients & Healthy Volunteers
Become A Member
Search Clinical Trials
About Us
About Clinical Trials
Virtual Clinical Trials
Latest Blog Posts
Health News
Patient Login
Patient Recruitment
Services for Research Sites
Study Listings
Clinical Ad Network™
Patient Direct Mail Alerts
Create Partner Account
Partner Login
National Recruitment Services
Multicenter Study Listings
Digital Marketing Strategies
Site Identification Services
Virtual Clinical Trials
Direct to Patient Advertising
News And Information
Case Studies
Patient Recruitment Insider Blog
Web Development
For Research Sites
Study Screening Websites
Home
Search Results from Other Databases
Search Results
Zip Code
Keyword (Optional)
Distance
5 miles
10 miles
25 miles
50 miles
100 miles
250 miles
Any Distance
Search International Trials
Enter your email to receive notifications about clinical trials.
envelope
Top Searches
Healthy Volunteers
Alzheimer's Disease
COPD/Emphysema
Mild Cognitive Impairment (MCI)
Dementia
Depression
Narcolepsy
Diabetes Type 2
Stroke
Diabetic Nerve Damage (Diabetic Peripheral Neuropathy)
Search Results from
C
linical
C
onnection
SEARCH RESULTS FROM
C
LINICAL
C
ONNECTION
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screeni
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST
Study of Acute Uncomplicated Seasonal Influenza A in Adult Subjects
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Sub
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Partic
Global Prevalence of ATTR-CM in Participants With HFpEF
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)
Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic
Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
Breast Cancer Index (BCI) Registry
Naptumomab Estafenatox (NAP) in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanc
Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe CKD
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Effectiveness of CRD-740 in Heart Failure
A Study of Ponsegromab in People With Heart Failure
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)
Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of IBS-C
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in Peopl
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Cons
Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH
A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Ol
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.